Tiletamine hydrochloride

CAS No. 14176-50-2

Tiletamine hydrochloride( CI-634 | CL-399 | CN 54521-2 | NSC 167740 )

Catalog No. M11743 CAS No. 14176-50-2

Proposed anesthetic with possible anticonvulsant and sedative properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tiletamine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Proposed anesthetic with possible anticonvulsant and sedative properties.
  • Description
    Proposed anesthetic with possible anticonvulsant and sedative properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CI-634 | CL-399 | CN 54521-2 | NSC 167740
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    NMDAR
  • Recptor
    NMDA receptor
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    14176-50-2
  • Formula Weight
    259.8
  • Molecular Formula
    C12H17NOS·ClH
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 40mg/mL
  • SMILES
    Cl.CCNC1(CCCCC1=O)C1=CC=CS1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Klockgether T, et al. Brain Res. 1988 Oct 4;461(2):343-8.
molnova catalog
related products
  • Cycloleucine

    Cycloleucine is an antagonist of NMDA receptor associated glycine receptor with a Ki of 600 μM. Cycloleucine is also a competitive inhibitor of S-adenosyl-methionine mediated methylation with anxiolytic and cytostatic effects.

  • TCN213

    TCN213 is an antagonist of NMDA receptor that has a selective for NR1/NR2A over NR1/NR2BTCN 213 antagonism of GluN1/GluN2A NMDA receptors was dependent on glycine but independent of glutamate concentrations in external recording solutions.

  • NMDA-IN-1

    NMDA-IN-1 is a potent and NR2B-selective antagonist of NMDA(NMDA Ki of 0.85 nM; NR2B Ca2+ influx IC50 is 9.7 nM).